69238-2095-3 : NDC 2025 Code

69238-2095-3 : Emtricitabine And Tenofovir Disoproxil Fumarate ( Emtricitabine And Tenofovir Disoproxil Fumarate )

Additionally :

You can get information about “69238-2095-3” NDC code in 69238-2095-3 in HTML format

HTML | 69238-2095-3 in TXT (Plain Text) format

TXT | 69238-2095-3 in PDF (Portable Document Format)

PDF | 69238-2095-3 in XML format

XML formats.

NDC Code : 69238-2095-3 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "69238-2095-3",
    "PackageDescription": "30 TABLET, FILM COATED in 1 BOTTLE (69238-2095-3) ",
    "NDC11Code": "69238-2095-03",
    "ProductNDC": "69238-2095",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Emtricitabine And Tenofovir Disoproxil Fumarate",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Emtricitabine And Tenofovir Disoproxil Fumarate",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20180826",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA209721",
    "LabelerName": "Amneal Pharmaceuticals NY LLC",
    "SubstanceName": "EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE",
    "StrengthNumber": "200; 300",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-01-02",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20180826",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}